Drug intelligence / Profile preview

sodium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride + magnesium chloride

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Sodium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride + magnesium chloride** is a sterile balanced crystalloid intravenous electrolyte solution marketed as **Normosol-R**. It contains sodium, chloride, potassium, magnesium, acetate, and gluconate at concentrations intended to approximate extracellular fluid and support restoration of intravascular and interstitial volume following acute extracellular fluid loss. Acetate and gluconate are metabolizable bicarbonate precursors that provide an alkalinizing effect. The product is used for fluid and electrolyte replacement in settings including surgery, trauma, burns, shock, and moderate blood loss; it is not a substitute for blood products during uncontrolled hemorrhage or severe red-cell depletion. Current US labeling identifies ICU Medical as the packager and manufacturer. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e089a44-0cee-4804-8f6f-8508508ddb5c))

Brand names
Normosol-RNormosol-R pH 7.4
Other names
multiple electrolytes injection type 1

Beyond the preview

Go deeper on sodium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride + magnesium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride + magnesium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call